Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Tirzepatide

    Virtual Booth

    Contact Supplier

    Mesochem Tirzepatide

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Tirzepatide

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Tirzepatide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 611,071Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Mounjaro

    02 2Zepbound

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Mounjaro

    Tirzepatide

    arrow
    Simposio AFI
    Not Confirmed

    Brand Name : Mounjaro

    U.S.A
    arrow
    Simposio AFI
    Not Confirmed

    Eli Lilly

    Tirzepatide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2022 Revenue in Millions : 483

    2021 Revenue in Millions : 0

    Growth (%) : New Launch in 2022

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Zepbound

    Tirzepatide

    arrow
    Simposio AFI
    Not Confirmed

    Brand Name : Zepbound

    U.S.A
    arrow
    Simposio AFI
    Not Confirmed

    Eli Lilly

    Tirzepatide

    Main Therapeutic Indication : Nutritional Deficiency

    Currency : USD

    2023 Revenue in Millions : 176

    2022 Revenue in Millions : 0

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Mounjaro

    Tirzepatide

    arrow
    Simposio AFI
    Not Confirmed

    Brand Name : Mounjaro

    U.S.A
    arrow
    Simposio AFI
    Not Confirmed

    Eli Lilly

    Tirzepatide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2023 Revenue in Millions : 5,163

    2022 Revenue in Millions : 483

    Growth (%) : 970

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Zepbound

    Tirzepatide

    arrow
    Simposio AFI
    Not Confirmed

    Brand Name : Zepbound

    U.S.A
    arrow
    Simposio AFI
    Not Confirmed

    Eli Lilly

    Tirzepatide

    Main Therapeutic Indication : Nutritional Deficiency

    Currency : USD

    2024 Revenue in Millions : 4,926

    2023 Revenue in Millions : 176

    Growth (%) : 2,702

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Mounjaro

    Tirzepatide

    arrow
    Simposio AFI
    Not Confirmed

    Brand Name : Mounjaro

    U.S.A
    arrow
    Simposio AFI
    Not Confirmed

    Eli Lilly

    Tirzepatide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2024 Revenue in Millions : 11,540

    2023 Revenue in Millions : 5,163

    Growth (%) : 124

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF